DSFCL Fined ₹3.02 Lakh by BSE & NSE for Compliance Lapses
DCM Shriram Fine Chemicals Limited received fines totaling ₹3.02 lakh from BSE and NSE for non-compliance with SEBI LODR Regulations 17(1) and 17(1A) for the quarter ended June 30, 2026. Compliance issues related to board composition and director appointments were rectified by May 29, 2026, and July 15, 2026, respectively.
The total fine amount of ₹3.02 lakh is insignificant relative to the company's overall operations, and the company has confirmed no material impact on its financial or operational activities.
The company has been imposed with fines by stock exchanges for non-compliance with regulatory requirements.
DCM Shriram Fine Chemicals Limited (DSFCL) has been fined a total of ₹3,02,080 by both BSE Limited and the National Stock Exchange of India Limited (NSE) for non-compliance or delayed compliance with Regulations 17(1) and 17(1A) of the SEBI (LODR) Regulations, 2015, for the quarter ended June 30, 2026. The company received communications regarding these fines on August 25, 2026.
The fines include ₹1,65,200 for non-compliance with Regulation 17(1) (basic fine ₹1,40,000 plus 18% GST ₹25,200) and ₹1,36,880 for non-compliance with Regulation 17(1A) (basic fine ₹1,16,000 plus 18% GST ₹20,880), levied separately by BSE and NSE.
DSFCL clarified that a new Independent Director was inducted on the Board effective July 15, 2026, to comply with Regulation 17(1). Compliance with Regulation 17(1A) was rectified and completed on May 29, 2026. The company confirmed that it is now fully compliant with the applicable provisions of these regulations. The company stated that there is no material impact on its financial, operational, or other activities, except for the payment of the fine, which has been duly paid. The fines arose from a routine quarter-end Standard Operating Procedure (SOP) review process.
What to do with a filing like this
DCM Shriram Fine Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by DCM Shriram Fine Chemicals Limited. Read the original for the full detail.